SPI
17.391,52
PKT
-153,53
PKT
-0,88
%
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 31.05.12 | Swiss Re overweight | J.P. Morgan Cazenove | |
| 31.05.12 | ABB (Asea Brown Boveri) neutral | Exane-BNP Paribas SA | |
| 31.05.12 | Swiss Re buy | Sarasin Research | |
| 31.05.12 | Swiss Re add | Commerzbank Corp. & Markets | |
| 31.05.12 | Avolta (ex Dufry) buy | ING | |
| 31.05.12 | Holcim overweight | Morgan Stanley | |
| 31.05.12 | Holcim equal-weight | Morgan Stanley | |
| 31.05.12 | Swiss Life hold | Société Générale Group S.A. (SG) | |
| 31.05.12 | Newron PharmaceuticalsAz. buy | Vontobel Research | |
| 31.05.12 | Swiss Re buy | Vontobel Research | |
| 31.05.12 | SHL Telemedicine hold | Vontobel Research | |
| 31.05.12 | Novartis buy | Deutsche Bank AG | |
| 30.05.12 | Roche buy | Deutsche Bank AG | |
| 30.05.12 | EFG International reduce | Sarasin Research | |
| 30.05.12 | Novartis outperform | Credit Suisse Group | |
| 30.05.12 | Orascom Development neutral | Sarasin Research | |
| 30.05.12 | Holcim outperform | Exane-BNP Paribas SA | |
| 30.05.12 | Arbonia hold | Vontobel Research | |
| 30.05.12 | SHL Telemedicine hold | Vontobel Research | |
| 30.05.12 | Forbo International buy | Vontobel Research | |
| 29.05.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 29.05.12 | Novartis buy | UBS AG | |
| 29.05.12 | Novartis buy | UBS AG | |
| 29.05.12 | Avolta (ex Dufry) neutral | Sarasin Research | |
| 29.05.12 | UBS neutral | Sarasin Research | |
| 29.05.12 | Richemont kaufen | Euro am Sonntag | |
| 29.05.12 | Swisscom hold | Vontobel Research | |
| 29.05.12 | Swatch (I) buy | Vontobel Research | |
| 25.05.12 | Zurich Insurance buy | ING | |
| 25.05.12 | Emmi hold | Vontobel Research | |
| 25.05.12 | Newron PharmaceuticalsAz. kaufen | Hanseatischer Börsendienst | |
| 25.05.12 | Cicor Technologies buy | Vontobel Research | |
| 24.05.12 | Ypsomed hold | Vontobel Research | |
| 24.05.12 | Temenos buy | Vontobel Research | |
| 23.05.12 | Avolta (ex Dufry) buy | ING | |
| 23.05.12 | Sonova buy | Vontobel Research | |
| 23.05.12 | Novartis hold | Vontobel Research | |
| 23.05.12 | Schweiter hold | Vontobel Research | |
| 22.05.12 | Zurich Insurance halten | Independent Research GmbH | |
| 22.05.12 | Sonova neutral | Sarasin Research |